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Original ArticleComparative Evaluation of Angioscopy and Intravascular Ultrasound for Assessing
Plaque Protrusion During Carotid Artery Stenting ProceduresHiroshi Kondo1,2, Yoshihiro Kiura1,2, Shigeyuki Sakamoto2, Takahito Okazaki2, Fumiyuki Yamasaki2, Koji Iida2,
Atsushi Tominaga1,2, Kaoru Kurisu2-BACKGROUND: Evaluation of plaque protrusion after
carotid artery stenting (CAS) is important for predicting
periprocedural ischemic complications. In contrast to
intravascular ultrasound (IVUS), angioscopy allows direct
visualization of the plaque. The aim of this study was to
evaluate utility and safety of angioscopy during CAS and
compare it with IVUS.
-METHODS: The study included 13 carotid artery stenosis
lesions in 11 consecutive patients (mean age 70.5 years; 10
men) at a single center. During CAS procedure, poststenting
plaque protrusion was evaluated with angioscopy and IVUS.
-RESULTS: Mean level of internal carotid artery stenosis
was 79.2%. Eight lesions were symptomatic, and 5 lesions
were predicted to have vulnerable plaque by preprocedural
magnetic resonance imaging. A carotid WALLSTENT was
placed in all cases. After stenting, angioscopy provided
good visualization in all cases. Plaque protrusions were
observed in 1 case by IVUS and in 8 cases by angioscopy.
Diffusion-weighted imaging showed positive lesions in 3
cases (23%). For 2 of these lesions, plaque protrusions
were observed by angioscopy but not by IVUS. All lesions
associated with positive diffusion-weighted imaging find-
ings were observed to have yellow plaque on angioscopy.
-CONCLUSIONS: Angioscopy provided direct visualization
of stent lumens after CAS. Angioscopy detected more plaque
protrusion than IVUS and allowed clearer observation of
plaque characteristics. Angioscopy may be more useful thanKey words
- Angioscopy
- Carotid artery stenting
- Plaque protrusion
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CAS: Carotid artery stenting
CEA: Carotid artery endarterectomy
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WORLD NEUROSURGERY-: e1-e8,- 2019IVUS for examination of plaque protrusion and plaque
evaluation after CAS, especially for plaque identified as
potentially vulnerable by preprocedural examination.INTRODUCTIONn carotid artery stenting (CAS), plaque assessment is
extremely important for identifying patients at risk ofI ischemic complications, such as patients with protruding,
mobile, or vulnerable plaque, who may need additional treatment.
A plaque assessment is usually performed before the CAS pro-
cedure using carotid artery ultrasound and magnetic resonance
imaging (MRI). Intraprocedural evaluations are also important, in
which intravascular ultrasound (IVUS)1-3 or optical coherence to-
mography (OCT) is often used.4-6 However, IVUS and OCT provide
only an indirect view of the plaque. In contrast, angioscopy can
directly visualize the vascular lumen, showing the color of its
surface, small thrombi, plaque protrusion, and morphology. Since
the 1980s, endoscopy and then angioscopy have been recognized
as useful for identifying arteriosclerosis-related plaque in coronary
disease.7-13 However, there have been few reports about the use of
angioscopy for investigating carotid artery disease.14,15 In this
study, we observed vascular and stent lumens on angioscopy
during CAS procedures and evaluated the risk of ischemic
complication during the periprocedural period, comparing the
utility and safety of angioscopy in CAS with that of IVUS.PAES: Parodi antiemboli system
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Figure 1. Angioscopy system. (A) VISIBLE angioscopy catheter. (B) FT-203F imaging system based on 3
charge-coupled devices.
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Patients
The study included 13 carotid artery stenosis lesions in 11
consecutive patients (mean age 70.5 years; 10 men) between
February and September 2015. The angioscopy system used in this
study is recognized by insurance companies in Japan for use in
coronary artery disease, but not in carotid artery disease. The
ethical review board of our hospital approved its use for this study,
and written informed consent was obtained from all patients. The
study was conducted in accordance with the principles of the
Declaration of Helsinki. The inclusion criteria were as follows:
asymptomatic internal carotid artery (ICA) stenosis >80% of the
lumen diameter or symptomatic ICA stenosis >50% of the lumen
diameter was present; a high risk for endarterectomy existed ac-
cording to the criteria of the Stenting and Angioplasty with Pro-
tection in Patients at High Risk for Endarterectomy (SAPPHIRE)
study16; ICA stenosis suddenly progressed in the follow-up course
and the need of CAS was considered.
Plaque morphology and character were evaluated before the
procedure by black blood imaging and time-of-flight angiography
on MRI. Vulnerable plaque was defined as plaque exhibiting high
signal on T1-weighted or T2-weighted imaging compared with the
intensity of the parotid and maxillary glands or the existence of
high signal in the plaque on time-of-flight imaging. During the
CAS procedure, IVUS and angioscopy were performed and evalu-
ated before and after stenting. All patients underwent neurologic
examinations before and after the CAS procedure, and MRI
diffusion-weighted imaging (DWI) was acquired the day after
CAS to evaluate ischemic changes. The CAS, IVUS, ande2 www.SCIENCEDIRECT.com WORLD NEangioscopy procedures were based on procedures reported in a
previous study.14Carotid Artery Stenting
CAS procedures were performed according to our standard
technique with the modified Parodi antiemboli system (PAES)
and distal protection of the ICA by FilterWire EZ (Boson Sci-
entific, Marlborough, Massachusetts, USA) to prevent any distal
embolic complications under the condition of local anes-
thesia.14 For at least 2 weeks before the procedure, patients
received dual (1 patient) or triple (10 patients) antiplatelet
therapy combining aspirin (100 mg/day) with clopidogrel (75
mg/day) and/or cilostazol (200 mg/day). Ten patients were
also taking statins.
The procedure was as follows. After placing a 9-F long sheath
introducer in the femoral artery and a 4-F short sheath in the
femoral vein at the opposite side as a flow reversal system, the
patient was systemically heparinized with a heparin bolus, fol-
lowed by continued intravenous heparin throughout the CAS
procedure to maintain an activated clotting time >275seconds. A
9-F guiding catheter with an occlusion balloon (OPTIMO; Tokai
Medical Products, Inc., Aichi, Japan) was guided into the com-
mon carotid artery with a coaxial system using a 6-F inner
catheter (JB2; Medikit Co. Ltd., Tokyo, Japan) and a 0.035-inch
stiff guidewire (Radifocus Guidewire M Stiff type; Terumo Cor-
poration, Tokyo, Japan). The OPTIMO balloon was then con-
nected to a 4-F short sheath, which was placed in the femoral
vein through a filter for blood transfusion as a flow reversal
system. To prevent the backflow of blood from the externalUROSURGERY, https://doi.org/10.1016/j.wneu.2019.01.102
Figure 2. Carotid artery stenting and angioscopy
system. A modified Parodi antiemboli system with
distal protection was used. The angioscope was
inserted in the aspiration catheter and used with saline
flush. AC, aspiration catheter; CCA, common carotid
artery; CG, carotid GuardWire; ECA, external carotid
artery; FW, FilterWire EZ; GC, guiding catheter; ICA,
internal carotid artery; SThA, superior thyroid artery.
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apolis, Minnesota, USA) was placed in the ECA at the proximal
side of the bifurcation of the superior thyroid artery. Under the
flow reversal condition with the OPTIMO balloon and carotid
GuardWire inflated, a FilterWire EZ was gently passed through
the stenotic lesion and deployed in the petrous portion of the
ICA to provide distal protection. Before stenting, the OPTIMO
balloon was deflated to allow IVUS to be performed and then
reinflated to prevent the inflow of blood while angioscopy was
performed with a saline flush to wash out blood. Then under the
flow reversal condition, predilation for percutaneous trans-
luminal angioplasty was performed with a balloon selected ac-
cording to the size of a normal portion of the ICA. A carotid
WALLSTENT (Boston Scientific) was placed to completely cover
the plaque. After stenting, postdilation with the percutaneous
transluminal angioplasty balloon was followed by blood aspira-
tion using an aspiration catheter (Medtronic) until all debris had
been removed. The aspirated blood was infused via a filter
through the sheath at the femoral vein. After aspiration, IVUS
and angioscopy were performed again.
Intravascular Ultrasound
IVUS was performed using an Eagle Eye Platinum IVUS catheter
(Philips Corporation, San Diego, California, USA) with a Volcano
s5 IVUS imaging system (Philips Corporation). Plaque protrusionWORLD NEUROSURGERY-: e1-e8,- 2019was detected by ChromaFlo (Philips Corporation) IVUS, which
colorizes the flow, as defects in the flow.
Angioscopy
Angioscopy was performed using a VISIBLE Fiber angioscope
(FiberTech Co., Ltd., Tokyo, Japan) (external diameter of the
inserted part, 0.75 mm; effective length, 1620 mm) with an im-
aging system, FT-203F (FiberTech Co., Ltd.), based on 3 charge-
coupled devices (Figure 1). Once the modified PAES and distal
protection were in place, as described under Carotid Artery
Stenting, the angioscope was inserted into the aspiration
catheter and guided to the distal side of the carotid lesion.
With the blood flow to the ICA interrupted by the OPTIMO
balloon in the common carotid artery and the carotid
GuardWire in ECA, intraluminal blood was expelled by flushing
approximately 50 mL of physiologic saline through the OPTIMO
balloon, allowing the vascular and stent lumens to be clearly
observed (Figure 2).
Statistical Analysis
JMP Version 10 software (SAS Institute Inc., Cary, North Carolina,
USA) was used for statistical analysis. Data were compared by
using c2 test with Fisher exact test. P values <0.05 were consid-
ered statistically significant. Factors with P < 0.3 in c2 tests were
included in multivariate logistic regression analysis.www.journals.elsevier.com/world-neurosurgery e3
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This study enrolled 11 patients. Two patients had bilateral lesions;
thus, 13 lesions were analyzed. In the preprocedural plaque eval-
uations, the mean level of ICA stenosis was 79.2%. Of lesions, 8
were symptomatic, and 5 were asymptomatic; 5 were identified as
potentially having vulnerable plaque on preprocedural MRI. All
lesions were treated with a carotid WALLSTENT, and additional
stenting was needed in only 1 case (Table 1). No patient exhibited
any new neurologic deficit after CAS.
After stenting, angioscopy provided good visualization in all
cases with no difficulties. IVUS revealed plaque protrusion in only
1 lesion in case 4, whereas angioscopy showed plaque protrusions
in 8 lesions (Figure 3 and Table 2); this difference in detection rate
was statistically significant (P ¼ 0.011). In case 4, fluttering plaqueVideo available at
www.sciencedirect.comprotrusion in the stent was observed by angioscopy
but was not recognized by IVUS (Videos 1 and 2).
The plaque protrusion pointed out by IVUS was
described more clearly by angioscopy (Figure 3). In
4 lesions, yellow plaques were observed on
angioscopy, but not on IVUS.
DWI in the postprocedural MRI showed high-
intensity spots in the ipsilateral cerebral hemi-
sphere with 3 of the lesions (23%). Two of these lesions had
been identified as potentially having vulnerable plaque on pre-
procedural MRI. In 2 of the 3 lesions, DWI-positive plaque
protrusions could not be observed by IVUS; however, in these
lesions, plaque protrusion could be observed by angioscopy
(Table 2). All DWI-positive lesions after CAS were observed on
angioscopy to have yellow plaque protrusions. The only factor to
show a statistically significant relationship with the DWI-
positive lesions was the existence of yellow plaque observed
by angioscopy (P ¼ 0.014) (Table 3). Multivariate logistic
regression analysis revealed that the existence of yellow plaqueTable 1. Basic Characteristics of Patients
Case Age (Years)/Sex Symptoms Side Stenos
1 76/M Asymptomatic Left 70
2 80/M Symptomatic Right 95
3 72/M Symptomatic Right 95
4 67/M Symptomatic Right 90
4 67/M Symptomatic Left 84
5 50/F Symptomatic Right 87
6 68/M Symptomatic Left 95
7 66/M Asymptomatic Right 80
8 72/M Asymptomatic Left 67
9 70/M Asymptomatic Right 58
10 72/M Symptomatic Left 50
10 72/M Symptomatic Right 82
11 79/M Asymptomatic Right 86
APT, antiplatelet therapy; M, male; A, aspirin; Cl, clopidogrel; Ci, cilostazol; CW, carotid WALLST
e4 www.SCIENCEDIRECT.com WORLD NEwas the only factor that had a significant relationship with
DWI-positive lesions, as observed using postprocedural MRI
(P ¼ 0.033) (Table 3).DISCUSSION
Since the SAPPHIRE report in 2004 and the Carotid Revasculari-
zation Endarterectomy versus Stenting Trial (CREST) in 2010, CAS
has been performed to treat patients with evidence for high risk
and standard risk for carotid artery endarterectomy (CEA).16,17
However, the risk of periprocedural ischemic complications is
higher with CAS than with CEA. The CREST study reported more
frequent periprocedural cerebral ischemic complications in the
CAS group than in the CEA group (4.1% vs. 2.3%).17 Various
studies have reported DWI-positive findings after CAS in 17.is Rate
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%
ENT; F, female.
UROSURG3%e64% of cases3,18-22; however, these studies
differed in the technique used for the CAS procedure,
such as embolic protection, the type of stent used, and
whether there was predilation or postdilation. In a
systematic review, Schnaudigel et al.19 reported that
the rate of DWI-positive findings was significantly
higher with CAS than with CEA (37% vs. 10%). In CAS
using dual protection, the modified Parodi method,and distal protection with a filter wire in the ICA, the DWI-positive
rate was reported as 17.3%,21 a lower rate than with other
protection techniques; for this reason, we used the dual
protection technique in the present study. Angioscopy was used
in our study, and the DWI-positive rate was 23%, a level regar-
ded as tolerable compared with rates in past reports.
DWI-positive lesions after CAS have been reported to be
associated with ischemic events.23 In addition, a relationship
between the character of the plaque and the risk of
periprocedural ischemic complications with CAS has beenPlaque Appearance APT Stent
Stable A þ Cl þ Ci CW
Soft A þ Cl þ Ci CW
Soft A þ Cl þ Ci CW
Stable A þ Cl þ Ci CW þ CW
Stable A þ Cl þ Ci CW
Stable A þ Cl þ Ci CW
Stable A þ Cl þ Ci CW
Stable A þ Cl þ Ci CW
Stable A þ Cl þ Ci CW
Stable A þ Cl þ Ci CW
Soft Cl þ Ci CW
Soft Cl þ Ci CW
Soft Cl þ A þ Ci CW
ERY, https://doi.org/10.1016/j.wneu.2019.01.102
Figure 3. Plaque protrusion findings detected by
angioscopy and intravascular ultrasound. White
arrows point to white plaque protrusions (cases 1, 3,
6, 8, and 11). Yellow arrows point to yellow plaque
protrusions (case 4 bilaterally and case 10). Red
arrow points to a fluttering plaque protrusion (case 4,
right side C). The plaque protrusion detected by
intravascular ultrasound in case 4 on the right side
(case 4, right side B) as shown more clearly by
angioscopy (case 4, right side A). AS, angioscopy;
IVUS, intravascular ultrasound.
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Table 2. Findings Observed After Evaluation of Lumens of Stent
by Intravascular Ultrasound and Angioscopy
Case
Plaque
Protrusion
on IVUS
Plaque
Protrusion on
Angioscopy
DWI High
Spots
Neurologic
Change
1 No White plaque No No
2 No No No No
3 No White plaque No No
4 (right) Yes Yellow plaque
and flutter plaque
Yes No
4 (left) No Yellow plaque No No
5 No No No No
6 No White plaque No No
7 No No No No
8 No White plaque No No
9 No No No No
10 (left) No Yellow plaque Yes No
10 (right) No No No No
11 No Yellow plaque Yes No
IVUS, intravascular ultrasound; DWI, diffusion-weighted imaging.
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morphology is considered to be important. In reports of the
preprocedural evaluation of plaque morphology by carotid
ultrasound and MRI, the presence or absence of vulnerable
plaques, which are a risk factor for periprocedural cerebral
ischemic complication, has been proposed as an index.24-27 In
addition, it has been reported that there was a relationship be-
tween plaque volume measured with three-dimensional
T1-weighted gradient echo sequence on MRI and the rate of
DWI-positive at postprocedural MRI.28 In the present study, 3 of
5 lesions that had been identified as having potentially
vulnerable plaque before CAS showed DWI high-intensity
spots in the ipsilateral hemisphere on postprocedural MRI.Table 3. Comparison of Postprocedural Diffusion-Weighted Imaging
High-Intensity
Spot on DWI (n [ 3)
No High-Inte
Spot on DWI (n
Symptomatic 2 6
Vulnerable plaque by MRI 2 3
Plaque protrusion by IVUS 1 0
Plaque protrusion by AS 3 5
Yellow plaque by AS 3 1
DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging; IVUS, intravascular ultrasou
e6 www.SCIENCEDIRECT.com WORLD NEAlthough in this report there was no significant relationship
between the vulnerable plaque in preprocedural MRI and post-
procedural DWI-positive lesions, as indicated in some past re-
ports, the preprocedural evaluation of plaque is thought to be
important to help avoid ischemic complication after CAS.24-27
The intraprocedural evaluation of plaque protrusion and
thrombus is also considered to be important in CAS. If findings
associated with a high risk for ischemic complications, such as
plaque protrusion and vulnerable plaque, can be detected during
the procedure, additional treatment can be provided to avoid these
complications. Although there have been various reports of the
intraprocedural observation and evaluation during CAS procedures
of plaque protrusions in the stent lumen by IVUS1-3 and OCT,4-6
there have been only a few reports about the use of angioscopy
in CAS.14,15 Conversely, there have been several reports since the
1980s of use of angioscopy in coronary artery diseases.7-12 Uchida10
reviewed the angioscopic features of plaque, especially vulnerable
plaque, and evaluated the neointimal coverage of stents in the
coronary artery.
IVUS, OCT, and angioscopy allow real-time evaluation of plaque
properties before stent placement and the detection of plaque
protrusions after stent placement. The most significant difference
between IVUS orOCT and angioscopy is that angioscopy candirectly
visualize the lumen of the vessel and stent. However, a search of the
literature found no previous study that compared the evaluation of
plaque protrusions by angioscopy with that by IVUS or OCT in CAS.
Using IVUS, the frequency of detecting plaque protrusions after CAS
has been reported as 2.6%e7.8%.1,3 The rate of plaque prolapse
detected by OCT after CAS has been reported as 17.6%e40.2%.5,6 In
comparison, Tanemura et al.15 reported the frequency of plaque
protrusion identified by angioscopy after CAS to be 25%. Thus,
the rate of detection of plaque protrusion after CAS was higher
with angioscopy than with IVUS. This was consistent with the
findings of the present study, with angioscopy detecting 8 plaque
protrusions and IVUS detecting only 1. Of the 3 patients with
DWI-positive lesions on MRI after CAS, plaque protrusion was
detected by IVUS in only 1, whereas it was observed in all 3 patients
on angioscopy. The relationship between plaque protrusions
detected by both IVUS and angiography, DWI-positive lesions, and
ischemic complications has been reported.3However, in the present
study, 2 of 3 lesions with DWI-positive lesions were not observed as
plaque protrusion with IVUS. There was no statistically significant
relationship between plaque protrusion detected by IVUS,Between Factors
nsity
[ 10)
c2 Test with Fisher
Exact Test P Value
Multivariable Logistic
Regression Analysis P Value
1 —
0.511 —
0.23 0.41
0.231 1
0.014 0.033
nd; AS, angioscopy.
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DWI-positive lesions were observed to be yellow plaque protrusions
on angioscopy. In this study, only the yellow plaque protrusions
showed a statistically significant relationship with the DWI-positive
lesions. In coronary disease, there is an association between a yellow
plaque and the thickness of the fibrous cap of the plaque; hence,
yellow plaque detected by angioscopy has been considered to be
vulnerable.11 In coronary disease, an association between yellow
plaque and distal embolization of plaque debris has been
shown.12 It therefore appears that IVUS alone is insufficient for
evaluating plaque protrusion in CAS as well as in coronary
stenting. Thus, it may be better to evaluate the plaque protrusion
with angioscopy rather than IVUS alone when a lesion is
considered to be vulnerable plaque on preprocedural MRI.
The first problem of angioscopy is to obtain a clear view.
Tanemura et al.15 reported that a clear view was not obtained in
one third (6) of the lesions investigated, with insufficient
washout of blood experienced in 4 of those 6 lesions. It is
necessary to use a physiologic saline flush to expel the blood
almost completely from the vessel lumen. In that report,
embolic protection was provided by distal balloon protection
alone or PAES without distal protection from a filter device in
the ICA. Therefore, in the present study, the CAS procedure and
angioscopy were performed under proximal and distal
protection, modified PAES, and distal protection with a filter
device. The common carotid artery and ECA were occluded by
balloon, on the proximal side to the superior thyroid artery
where possible, allowing the blood flow to be reduced enough
to expel the blood with a saline flush. This allowed a clear view
to be obtained for all the lesions.
The second problem associated with angioscopy is the increase
in DWI-positive lesions from flushing saline to expel the blood in
the stent lumen. Tanemura et al.15 reported a relatively high DWI-
positive rate of 47%. Flushing saline to expel blood is thought to
involve the risk of transporting vulnerable plaques and debris
protruding into the stent lumen to the distal side, resulting in
ischemic complications during the periprocedural period. In the
present study, in addition to the modified PAES, a filter device in
the ICA was used for distal protection. The DWI-positive rate wasWORLD NEUROSURGERY-: e1-e8,- 2019lower than in the previous report (23% vs. 47%). Sakamoto et al.21
reported that proximal and distal protection can reduce the
DWI-positive rate. Using a similar method may therefore reduce
the DWI-positive rate even when angioscopy is used.
The next problem for angioscopy is the visual field. Tanemura
et al.15 reported that they were unable to obtain 360 observation
of the wall of the vessel. Although nearly the entire vessel wall
and stent could be observed in the present study, the narrow
angle of the visual field may restrict the absorbable area in the
lumen, especially in tortuous lesions.
The final problem related to angioscopy is decision making with
regard to the need for additional treatment. In the present study, 3
lesions were associated with DWI-positive findings on post-
procedural MRI, and 8 lesions were observed to have plaque pro-
trusion on angioscopy, with 4 observed to have yellow plaque. Only 1
lesion required an additional stent, and there were no new neuro-
logic deficits in any patient in the periprocedural period. It is unclear
which findings by angioscopy after stenting require additional
treatment to avoid periprocedural complications; this needs further
consideration. From the results of this study, for the lesion
considered as a vulnerable plaque in preoperative evaluation, when
the property of plaque protrusion after CAS using angioscopy con-
firms as a vulnerable plaque, such as a yellow plaque protrusion or a
fluttering plaque, additional treatment may be necessary.
A limitation of this study is that the results cannot be gener-
alized because of the limited number of lesions. To establish the
utility and safety of angioscopy, it is necessary to repeat this
investigation with a larger number of cases.CONCLUSIONS
Angioscopy allowed direct evaluation of the stent lumens,
providing clearer visualization of the lumens of vessel and stent
than with IVUS. As a consequence, angioscopy detected more
plaque protrusion and yellow, potentially vulnerable, plaque than
was possible with IVUS. Thus, angioscopy may be more useful
than IVUS for examination of plaque protrusion and plaque
evaluation after CAS, especially when plaque has been predicted to
be vulnerable by MRI before CAS.REFERENCES
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